98 related articles for article (PubMed ID: 35706412)
1. Long non-coding RNA HOXA11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer.
Chen Y; Cui Z; Wu Q; Wang H; Xia H; Sun Y
Bioengineered; 2022 May; 13(5):13893-13905. PubMed ID: 35706412
[TBL] [Abstract][Full Text] [Related]
2. Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis.
Zhang XY; Zhu BC; He M; Dong SS
J Ovarian Res; 2024 May; 17(1):102. PubMed ID: 38745302
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines.
Jin L; Huo Y; Zheng Z; Jiang X; Deng H; Chen Y; Lian Q; Ge R; Deng H
Mol Cell Proteomics; 2014 Nov; 13(11):3138-51. PubMed ID: 25096996
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer.
Noriega-Rivera R; Rivera-Serrano M; Rabelo-Fernandez RJ; Pérez-Santiago J; Valiyeva F; Vivas-Mejía PE
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887085
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway.
Xiao L; Shi XY; Li ZL; Li M; Zhang MM; Yan SJ; Wei ZL
J Gynecol Oncol; 2021 Sep; 32(5):e77. PubMed ID: 34132072
[TBL] [Abstract][Full Text] [Related]
6. Autophagy regulated by lncRNA HOTAIR contributes to the cisplatin-induced resistance in endometrial cancer cells.
Sun MY; Zhu JY; Zhang CY; Zhang M; Song YN; Rahman K; Zhang LJ; Zhang H
Biotechnol Lett; 2017 Oct; 39(10):1477-1484. PubMed ID: 28721581
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics.
Yang Y; Liu L; Tian Y; Gu M; Wang Y; Ashrafizadeh M; Reza Aref A; Cañadas I; Klionsky DJ; Goel A; Reiter RJ; Wang Y; Tambuwala M; Zou J
Cancer Lett; 2024 Apr; 587():216659. PubMed ID: 38367897
[TBL] [Abstract][Full Text] [Related]
8. Association between circadian gene
Xu H; Wang Z; Mo G; Chen H
Oncol Lett; 2018 Jun; 15(6):8945-8950. PubMed ID: 29844814
[TBL] [Abstract][Full Text] [Related]
9. The role and function of autophagy through signaling and pathogenetic pathways and lncRNAs in ovarian cancer.
Mirabdali S; Ghafouri K; Farahmand Y; Gholizadeh N; Yazdani O; Esbati R; Hajiagha BS; Rahimi A
Pathol Res Pract; 2024 Jan; 253():154899. PubMed ID: 38061269
[TBL] [Abstract][Full Text] [Related]
10. Ellagic Acid and Resveratrol Prevent the Development of Cisplatin Resistance in the Epithelial Ovarian Cancer Cell Line A2780.
Engelke LH; Hamacher A; Proksch P; Kassack MU
J Cancer; 2016; 7(4):353-63. PubMed ID: 26918049
[TBL] [Abstract][Full Text] [Related]
11. ATP6V1B1 regulates ovarian cancer progression and cisplatin sensitivity through the mTOR/autophagy pathway.
Mo S; Liu T; Zhou H; Huang J; Zhao L; Lu F; Kuang Y
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38735913
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound coupled RES-loaded ultrasound microbubble inhibits the proliferation of ovarian cancer cells by expression of long non-coding RNA (lncRNA) involved in apoptosis using real-time PCR.
Ying H; Ye L
Am J Cancer Res; 2023; 13(9):4434-4445. PubMed ID: 37818064
[TBL] [Abstract][Full Text] [Related]
13. Autophagy-related gene PXN as a prognostic marker: Promotion of ovarian cancer progression by suppressing the p110β/Vps34/Beclin1 pathway.
Wu Q; Cui Z; Jiang S; Xia H; Liu L; You Y; Sun Y
Cell Biochem Funct; 2023 Jul; 41(5):599-608. PubMed ID: 37232085
[TBL] [Abstract][Full Text] [Related]
14. Targeting HOXA11-AS to mitigate prostate cancer via the glycolytic metabolism: In vitro and in vivo.
Zhang J; Li S; Zhang M; Wang Z; Xing Z
J Cell Mol Med; 2024 Apr; 28(8):e18227. PubMed ID: 38520207
[TBL] [Abstract][Full Text] [Related]
15. CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids.
Wang H; Zhang Y; Miao H; Xu T; Nie X; Cheng W
Cancer Cell Int; 2024 Jan; 24(1):42. PubMed ID: 38273320
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analyses of mitophagy-related genes and mitophagy-related lncRNAs for patients with ovarian cancer.
Zheng J; Jiang S; Lin X; Wang H; Liu L; Cai X; Sun Y
BMC Womens Health; 2024 Jan; 24(1):37. PubMed ID: 38218807
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs: controversial roles in drug resistance of solid tumors mediated by autophagy.
Saadh MJ; Almoyad MAA; Arellano MTC; Maaliw RR; Castillo-Acobo RY; Jalal SS; Gandla K; Obaid M; Abdulwahed AJ; Ibrahem AA; Sârbu I; Juyal A; Lakshmaiya N; Akhavan-Sigari R
Cancer Chemother Pharmacol; 2023 Dec; 92(6):439-453. PubMed ID: 37768333
[TBL] [Abstract][Full Text] [Related]
18. Autophagy-related lncRNAs in tumor progression and drug resistance: A double-edged sword.
Zhang Y; Tang J; Wang C; Zhang Q; Zeng A; Song L
Genes Dis; 2024 Jan; 11(1):367-381. PubMed ID: 37588204
[TBL] [Abstract][Full Text] [Related]
19. FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer.
Jiang S; Zheng J; Cui Z; Li Y; Wu Q; Cai X; Zheng C; Sun Y
Front Cell Dev Biol; 2023; 11():1200197. PubMed ID: 37457292
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
